autoimmune disease
The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.
The alliance will result in the integration of transcriptome genomic data from Scipher's PrismRA Test into OMNY Health's EHR network.
The company will use the funds to increase the development of its computational platform to predict patient treatment responses and support drug research & development.
Employees of Maven will have access to WellTheory's platform for individuals with autoimmune diseases, including a collaborative care team and ongoing guidance.